ReviewHematology, transfusion and cell therapy
Is asciminib an effective tyrosine kinase inhibitor for chronic myeloid leukemia patients with tyrosine kinase inhibitor resistance?
Musab Ma Omar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.